Yubai Zhou

517 total citations
10 papers, 348 citations indexed

About

Yubai Zhou is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, Yubai Zhou has authored 10 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Immunology. Recurrent topics in Yubai Zhou's work include Synthesis and Catalytic Reactions (4 papers), Asymmetric Synthesis and Catalysis (3 papers) and Phagocytosis and Immune Regulation (3 papers). Yubai Zhou is often cited by papers focused on Synthesis and Catalytic Reactions (4 papers), Asymmetric Synthesis and Catalysis (3 papers) and Phagocytosis and Immune Regulation (3 papers). Yubai Zhou collaborates with scholars based in United States, Germany and Australia. Yubai Zhou's co-authors include William D. Wulff, Munmun Mukherjee, Anil K. Gupta, Manishabrata Bhowmick, Sarah L. J. Trice, Heather M. Lima, Barbara Mikulak-Klucznik, Sara Szymkuć, Michael P. McCormack and Ewa Gajewska and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Chemistry - A European Journal.

In The Last Decade

Yubai Zhou

8 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yubai Zhou United States	7	141	134	134	103	65	10	348
Ariel Adamski Poland	7	111 0.8×	160 1.2×	141 1.1×	82 0.8×	66 1.0×	9	348
Michael P. McCormack United States	5	110 0.8×	135 1.0×	133 1.0×	81 0.8×	65 1.0×	5	305
Oskar Popik Poland	7	141 1.0×	131 1.0×	117 0.9×	99 1.0×	57 0.9×	10	317
Heather M. Lima United States	7	112 0.8×	136 1.0×	135 1.0×	158 1.5×	67 1.0×	8	391
Michael Maser United States	9	107 0.8×	186 1.4×	143 1.1×	132 1.3×	63 1.0×	9	395
Nidhal Selmi United Kingdom	10	175 1.2×	102 0.8×	121 0.9×	67 0.7×	30 0.5×	15	367
A. Zuranski United States	5	71 0.5×	197 1.5×	137 1.0×	136 1.3×	69 1.1×	7	383
Valerio Zullo Italy	6	125 0.9×	172 1.3×	160 1.2×	44 0.4×	51 0.8×	13	342
Michał D. Bajczyk Poland	7	224 1.6×	293 2.2×	283 2.1×	49 0.5×	113 1.7×	9	520
Marius Kühnemund Germany	4	72 0.5×	238 1.8×	173 1.3×	60 0.6×	78 1.2×	4	339

Countries citing papers authored by Yubai Zhou

Since Specialization

Citations

This map shows the geographic impact of Yubai Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yubai Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yubai Zhou more than expected).

Fields of papers citing papers by Yubai Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yubai Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yubai Zhou. The network helps show where Yubai Zhou may publish in the future.

Co-authorship network of co-authors of Yubai Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yubai Zhou. A scholar is included among the top collaborators of Yubai Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yubai Zhou. Yubai Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Zhou, Yubai, Desmarini Desmarini, Michael A. Stashko, et al.. (2025). Design, Synthesis, and Cellular Characterization of a New Class of IPMK Kinase Inhibitors. Journal of Medicinal Chemistry. 68(15). 15446–15460. 1 indexed citations

Kong, Deyu, Jichen Zhao, Michael A. Stashko, et al.. (2025). Discovery of Novel TYRO3/MERTK Dual Inhibitors. Journal of Medicinal Chemistry. 68(8). 8455–8470.

Zhou, Yubai, Molee Chakraborty, Chunfang Gu, et al.. (2022). Development of Novel IP6K Inhibitors for the Treatment of Obesity and Obesity-Induced Metabolic Dysfunctions. Journal of Medicinal Chemistry. 65(9). 6869–6887. 21 indexed citations

Wang, Li, Yubai Zhou, Xuedan Wu, et al.. (2022). The Synthesis and Initial Evaluation of MerTK Targeted PET Agents. Molecules. 27(5). 1460–1460.

Zheng, Hongchao, Jichen Zhao, Bing Li, et al.. (2021). UNC5293, a potent, orally available and highly MERTK-selective inhibitor. European Journal of Medicinal Chemistry. 220. 113534–113534. 8 indexed citations

Klucznik, Tomasz, Barbara Mikulak-Klucznik, Michael P. McCormack, et al.. (2018). Efficient Syntheses of Diverse, Medicinally Relevant Targets Planned by Computer and Executed in the Laboratory. Chem. 4(3). 522–532. 246 indexed citations

Zhou, Yubai, Munmun Mukherjee, Anil K. Gupta, & William D. Wulff. (2017). Multicomponent cis- and trans-Aziridinatons in the Syntheses of All Four Stereoisomers of Sphinganine. Organic Letters. 19(9). 2230–2233. 17 indexed citations

Zhou, Yubai, Anil K. Gupta, Munmun Mukherjee, Zheng Li, & William D. Wulff. (2017). Multicomponent Catalytic Asymmetric Synthesis of trans-Aziridines. The Journal of Organic Chemistry. 82(24). 13121–13140. 15 indexed citations

Mukherjee, Munmun, et al.. (2016). Catalyst‐Controlled Multicomponent Aziridination of Chiral Aldehydes. Chemistry - A European Journal. 23(11). 2552–2556. 8 indexed citations

10.

Mukherjee, Munmun, Yubai Zhou, Anil K. Gupta, Yong Guan, & William D. Wulff. (2014). A General Synthesis of Sphinganines through Multicomponent Catalytic Asymmetric Aziridination. European Journal of Organic Chemistry. 2014(7). 1386–1390. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact